CNBC Daily Open: Oil surges as Iran war enters seventh day

CNBC Daily Open: Oil surges as Iran war enters seventh day


Storage tanks are seen at Marathon Petroleum’s Los Angeles Refinery, which processes domestic and imported crude oil, in Carson, California, on March 11, 2022.

Bing Guan | Reuters

What you need to know today

Crude oil crossed $80 per barrel Thursday, as the Iran war enters its seventh day and continues disrupting global fuel supplies. Iran’s Foreign Minister Abbas Araghchi said Thursday that his country was “not asking for a ceasefire” from the U.S. and Israel, while President Donald Trump said that his administration will turn its focus to Cuba after the U.S. military operations in Iran are finished.

Besides energy disruption, the turmoil in the Middle East has shattered Dubai’s status as a global wealth hub, as the rich scramble to escape the largely tax-free haven. Over the past week, UAE has seen projectiles hit tourist and civilian spaces, including the 5-star Fairmont The Palm Hotel and the Dubai airport. 

Over in the U.S., the Anthropic-OpenAI rivalry continues. OpenAI CEO Sam Altman took swipes at rival Anthropic on Thursday and said he thinks it’s “bad for society” if companies start abandoning their commitment to the democratic process because “some people don’t like the person or people currently in charge.” That comes after the Department of Defense clashed with Anthropic in recent weeks over how the agency can use its AI models.

Adding another layer of uncertainty to markets, Trump’s tariffs face a new legal battle after New York Attorney General Letitia James and the top prosecutors of 23 other states once again sued to block his global tariff regime, just days after a landmark Supreme Court decision struck down his previous effort.

And finally…

Iran’s Shahed drone: How ‘the poor man’s cruise missile’ is shaping Tehran’s retaliation

The Shahed-136 ‘kamikaze’ drone has become central to Iran’s retaliation strategy against the U.S. and its regional allies, with thousands unleashed so far.

First designed in Iran, the weapon has already become a fixture of modern warfare, with Tehran’s strategic partner, Russia, utilizing the technology in its years-long battle with Ukraine.

Though drone seems unremarkable compared with cutting-edge weapon technologies and the majority have been struck down by American allies, many Shaheds have still managed to hit their targets.

“The Shahed‑136, among other unmanned aerial systems, has allowed states like Russia and Iran a cheap way to impose disproportionate costs,” an analyst said.

— Dylan Butts



Source

‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock
World

‘Misplaced euphoria’: Markets are sleepwalking into a recession amid Iran war oil price shock

Global economies could be “sleepwalking” into a “big recession”, as investors continue to underplay the impact of the oil price shock, Amrita Sen, founder and director, market intelligence at Energy Aspect, told CNBC’s “Squawk Box Europe” on Monday. The S&P 500 hit a new all-time intraday high last week, with the broad market index touching […]

Read More
Stocks making the biggest moves premarket: eBay, Norwegian Cruise Line, Coinbase & more
World

Stocks making the biggest moves premarket: eBay, Norwegian Cruise Line, Coinbase & more

Check out the companies making the biggest moves premarket: eBay — Shares of the online marketplace jumped nearly 9% after GameStop made an unsolicited, non-binding offer Sunday to buy eBay for roughly $55.5 billion. GameStop CEO Ryan Cohen said the merger would be a way to create a strong competitor to Amazon . GameStop fell […]

Read More
‘Bubble effect’: Weight loss drug fueled growth is putting the pharma sector at risk, report finds
World

‘Bubble effect’: Weight loss drug fueled growth is putting the pharma sector at risk, report finds

Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a “bubble effect” as profitability soars, new research suggests. Demand for the likes of Wegovy and Zepbound has driven research and development returns to their highest level in years, but a report published by Deloitte on Monday suggests this is […]

Read More